A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures.

Published in: The Journal of bone and joint surgery. American volume (2020)

Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

Keyphrases